GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
BIODEL INC. (BIOD) [hlAlert]

Biodel Inc. (Biodel) is a development-stage specialty pharmaceutical company located in Danbury, Connecticut. The Company is focused on the development and commercialization of treatments for endocrine disorders, such as diabetes and osteoporosis. The Company develops product candidates by applying its formulation technologies to existing drugs in
order to improve their therapeutic results. The Company?s initial development efforts are focused on peptide hormones. The Company?s advanced product candidate, VIAject, has been studied in two pivotal Phase III clinical trials for the treatment of patients with Type 1 and Type 2 diabetes. Earlier stage product candidates include VIAtab, a sublingual tablet formulation of insulin and two preclinical product candidates for the treatment of osteoporosis. The Company has developed all of its product candidates utilizing its VIAdel technology that allows the Company to study the interaction between peptide hormones and small molecules.
.
( Total: 12 Current Stock Recommendations )
BIODEL INC.   (12)
Sell Hold Buy 83%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold BIOD
BIODEL INC. (BIOD) downgraded to Neutral by Ladenburg Thalmann
Friday,  Dec 18, 2015  4:25 PM ET

Rating:
Buy BIOD
down 43.33 %

Rating:
Buy BIOD

Rating:
Buy BIOD
down 71.66 %

Rating:
Buy BIOD
down 91.74 %

Rating:
Buy BIOD
down 91.05 %

Rating:
Buy BIOD
down 91.05 %

Rating:
Buy BIOD
down 91.05 %

Rating:
Hold BIOD

Rating:
Hold BIOD
BIODEL INC. (BIOD) rated Mkt Perform by JMP Securities
Tuesday,  Oct 19, 2010  10:25 AM ET

Rating:
Buy BIOD
down 61.46 %

Rating:
Buy BIOD
down 96.63 %
BIODEL INC. (BIOD) rated Buy with price target $16 by Wedbush Morgan
Wednesday,  Mar 25, 2009  11:25 AM ET

Rating:
Buy BIOD
down 93.14 %

Rating:
Buy BIOD
down 98.95 %

Rating:
Sell BIOD
up 3,041.17 %
BIODEL INC. (BIOD) rated Sell by Argus
Friday,  Sep 19, 2008  9:25 AM ET

Your Recent Stocks
SymbolLastChange
BIOD 0.31 down  -54.85 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy